Increased oxidative stress is well known in Cystic Fibrosis (CF) patients. Studies still address the question if CF patients need higher antioxidant plasma concentrations than healthy subjects. Objective: To assess if “normal” values of plasma antioxidants counterbalance adequately oxidative stress in stable CF patients with or w/o pancreatic insufficiency (p.i). 70 patients were recruited during a routine visit in our CF Regional Center (32M/38F, median age 7.8, 36/70 with p.i.) whose 91% with vitamin supplementation. Red-ox status as: plasma or erythrocytes antioxidants: vit. E, A, C, selenium (Se), reduced (GSH) and oxidised (GSSG) glutathione, GSHPx; lipid oxidation markers: chromolipids (MDA and HNE aldehydes). Conclusions: “Normal” antioxidant plasma levels do not provide adequate control on oxidative stress markers that are directly correlated with aging, pancreatic insufficiency and indirectly correlated with plasma levels of antioxidant vitamins.

Oxidative stress in stable CF patients: do we need higher antioxidant plasma levels?

BIASI, Fiorella;SANTINI, Bruna;
2010-01-01

Abstract

Increased oxidative stress is well known in Cystic Fibrosis (CF) patients. Studies still address the question if CF patients need higher antioxidant plasma concentrations than healthy subjects. Objective: To assess if “normal” values of plasma antioxidants counterbalance adequately oxidative stress in stable CF patients with or w/o pancreatic insufficiency (p.i). 70 patients were recruited during a routine visit in our CF Regional Center (32M/38F, median age 7.8, 36/70 with p.i.) whose 91% with vitamin supplementation. Red-ox status as: plasma or erythrocytes antioxidants: vit. E, A, C, selenium (Se), reduced (GSH) and oxidised (GSSG) glutathione, GSHPx; lipid oxidation markers: chromolipids (MDA and HNE aldehydes). Conclusions: “Normal” antioxidant plasma levels do not provide adequate control on oxidative stress markers that are directly correlated with aging, pancreatic insufficiency and indirectly correlated with plasma levels of antioxidant vitamins.
2010
33rd European Cystic Fibrosis Conference
Valencia (Spagna)
16-19 giugno 2010
9
suppl 1
S92
-
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6X2D-50HXGY1-DS&_user=525216&_coverDate=06%2F30%2F2010&_rdoc=358&_fmt=high&_orig=browse&_origin=browse&_zone=rslt_list_item&_srch=doc-info(%23toc%237268%232010%23999909999.8998%232212761%23FLT%23display%23Volume)&_cdi=7268&_sort=d&_docanchor=&view=c&_ct=465&_acct=C000026382&_version=1&_urlVersion=0&_userid=525216&md5=1079b840583b623f3fc3593cd5992946&searchtype=a
cystic fibrosis; oxidative stress; antioxidants
Lezo A; Biasi F; Santini B; Massarenti P.; Calabrese R; Bignamini E
File in questo prodotto:
File Dimensione Formato  
ID_481403.pdf

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 48.71 kB
Formato Adobe PDF
48.71 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/74784
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact